Myomo Q2 revenue rises 21% to $11.7 million; full-year revenue guidance raised
Myomo reported second quarter 2026 revenue of $11.7 million, up 21% from a year earlier, and narrowed its net loss to $4.0 million, or $0.09 per share, from $4.6 million, or $0.11 per share. The company raised its full-year 2026 revenue guidance to $45 million to $47 million, which signals expected higher sales for shareholders.
Key points
- Q2 2026 revenue was $11.7 million, up 21% from $9.7 million in Q2 2025; gross margin was 72.1% versus 62.7%.
- Q2 2026 net loss was $4.0 million ($0.09 per share), including a $1.2 million non-cash derivative charge, compared with $4.6 million ($0.11 per share) a year earlier.
- Full-year 2026 revenue guidance was raised to $45 million to $47 million; Q3 2026 revenue is expected at $11.5 million to $12.0 million.
- Cash, cash equivalents and short-term investments were $13.5 million as of June 30, 2026; Q2 cash used in operating activities was $1.9 million.
The filing
Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.